Related Experiment Video

Updated: Jun 13, 2026

The use of SC1 (Pluripotin) to Support mESC Self-renewal in the Absence of LIF
05:58

The use of SC1 (Pluripotin) to Support mESC Self-renewal in the Absence of LIF

Published on: November 18, 2009

STAT1 represses Skp2 gene transcription to promote p27Kip1 stabilization in Ras-transformed cells

Shuo Wang1, Jennifer F Raven, Antonis E Koromilas

  • 1Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Room 508, 3999 Cote Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2. swang@ldi.jgh.mcgill.ca

Molecular Cancer Research : MCR
|April 22, 2010
PubMed

Insights

Signal transducer and activator of transcription 1 (STAT1) suppresses tumors by inhibiting Skp2 gene transcription, increasing p27(Kip1) stability. This reveals a new STAT1 pathway impacting cell transformation and tumorigenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • S-phase kinase-associated protein 2 (Skp2) is overexpressed in tumors, promoting cancer by degrading tumor suppressors like p27(Kip1).
  • Signal transducer and activator of transcription 1 (STAT1) has tumor-suppressor functions, inhibiting oncogenic pathways and enhancing immunosurveillance.

Purpose of the Study:

  • To elucidate a novel mechanism by which STAT1 upregulates p27(Kip1) in Ras-transformed cells.
  • To identify Skp2 as a direct transcriptional target of STAT1.

Main Methods:

  • In vitro and in vivo DNA binding assays to assess STAT1 interaction with the Skp2 promoter.
  • Analysis of Skp2 and p27(Kip1) expression levels in Ras-transformed and human colon cancer cells.
  • Investigation of p27(Kip1) protein stability following STAT1 modulation.

Main Results:

  • STAT1 directly binds to the Skp2 promoter, inhibiting its gene transcription.
  • STAT1-mediated downregulation of Skp2 leads to increased stability of the tumor suppressor p27(Kip1).
  • Impaired STAT1 expression in colon cancer cells correlates with elevated Skp2 and reduced p27(Kip1) levels.

Conclusions:

  • STAT1 functions as a transcriptional repressor of Skp2 in Ras-transformed cells.
  • The STAT1-Skp2-p27(Kip1) axis represents a novel pathway with significant implications for cell transformation and tumorigenesis.
  • Targeting this pathway could offer new therapeutic strategies for cancers with dysregulated STAT1 and Skp2 signaling.

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...